ABOUT US

  • Introduction
  • Vision
  • History
  • Organization
  • Affiliates
  • Locations

History

Home>ABOUT US>History

HISTORY
  • 2011 Completion of cGMP plant dedicated for carbapenem and general APIs
  • 2010 Expanded business to formulations (prescription, OTC, bio-based products)
    Sales revenue reaches 100 Million USD
  • 2009 Completion of Sichuan factory in China
    Company name changed from Daewoong Chemical Co., Ltd. to Daewoong Bio Inc.
  • 2007 Acquired Roche Korea plant at Ansung site
    Obtained CEP for Cefuroxime Axetil
  • 2006 Renewal of Factory 2 in Hyangnam
  • 2005 Acquired Lilly Korea plant at Hyangnam site
  • 2003 Obtained ISO 14001 Certificate for environmental management
  • 1999 Listed on KOSDAQ
  • 1998 Obtained BGMP through FDA
  • 1997 Registered as a member of the Korean Specialty Chemical Industry Association (KSCIA)
  • 1994 DMF approval by US FDA for Amoxicillin
  • 1993 Construction of Factory 2 in Hyangnam
    Merged with Samwoong Chemical Co.,Ltd
  • 1991 Research Institute established
  • 1983Daewoong Chemical Co., Ltd. established specializing in API manufacturing
    API manufacturing business initiated at Factory 1 in Hyangnam
AWARDS
  • 2011 Received award for“50 Million Dollar Exporter”
  • 2005 Coenzyme Q10 was nominated for“Korean World-class Product Award 2005”by the
    Minister of Commerce, Industry, and Energy
  • 2000 Nominated“Superior Company in High Technology Competitiveness”
  • 1999 Received award from the President of Korea on the 36th Trade Day
    Received award for“10 Million Dollar Exporter”
  • 1997 Received“Competent Manufacturer”approval by Gyeonggi Province Governor
  • 1990 Received award for“5 Million Dollar Exporter”
  • 1986 Received award for“1 Million Dollar Exporter”